European Commission Sign

The European Union’s vaccine-acquisition strategy

When phar­maceutical companies began distributing COVID-19 vaccines in late 2020 and early 2021, the European Union fell immediately behind the United Kingdom and United States in the number of doses administered. It faced shortages while, at the same time, allowing a substantial share of the vaccines it was receiving to be exported. This slow initial roll-out – which happened just as another wave of the pandemic was hitting many EU member states – has been extremely costly in human and economic terms and has battered the reputation of the European Commission.

Close shot of a vaccine being drawn from a vial into a syringe. The word COVID-19 floats in the background.

What we know about vaccine hesitancy

Visualisation of COVID-19 virus

Variants

The good the bad and government plans

Long COVID Research Monitor

timer on red alert background

Lessons Learned: Speed

Close shot of a vaccine being drawn from a vial into a syringe. The word COVID-19 floats in the background.

Research Monitor, April 13th

COVAX: A roadmap

Research Monitor, April 7th 2021